| |
| |
|
| Insider
Information: |
Smith Hunter C |
| Relationship: |
Chief Financial Officer |
| City: |
Darien |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
97,939 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,494,464 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
97,939 |
|
|
| Total
Value |
$3,494,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genesee & Wyoming Inc |
GWR |
Director |
2019-12-30 |
0 |
2015-03-31 |
0 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Chief Financial Officer |
2024-03-19 |
97,939 |
2018-09-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2019-09-30 |
4 |
A |
$110.67 |
$18,371 |
D/D |
166 |
11,824 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2019-12-30 |
4 |
D |
$112.00 |
$1,324,288 |
D/D |
(11,824) |
0 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2020-01-28 |
4 |
OE |
$6.88 |
$43,000 |
D/D |
6,250 |
22,250 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2020-03-13 |
4 |
OE |
$6.88 |
$24,080 |
D/D |
3,500 |
25,750 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
CFO and Interim CEO |
• – – |
2020-03-30 |
4 |
OE |
$6.88 |
$26,832 |
D/D |
3,900 |
29,650 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2021-01-19 |
4 |
OE |
$6.88 |
$27,520 |
D/D |
4,000 |
33,650 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2021-04-21 |
4 |
OE |
$6.88 |
$34,400 |
D/D |
5,000 |
38,650 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,344 |
40,994 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-02-15 |
4 |
AS |
$6.10 |
$5,081 |
D/D |
(833) |
40,161 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
65,161 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-07-01 |
4 |
AS |
$4.08 |
$30,792 |
D/D |
(7,547) |
57,614 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
55,114 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-02-09 |
4/A |
AS |
$27.51 |
$38,872 |
D/D |
(1,413) |
57,764 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-02-09 |
4 |
AS |
$27.66 |
$38,669 |
D/D |
(1,398) |
57,779 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,063 |
59,177 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,344 |
60,108 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-02-14 |
4 |
AS |
$26.87 |
$18,863 |
D/D |
(702) |
59,406 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-06-16 |
4 |
OE |
$6.88 |
$13,760 |
D/D |
2,000 |
61,406 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-11-14 |
4 |
OE |
$6.88 |
$82,560 |
D/D |
12,000 |
73,406 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-11-14 |
4 |
AS |
$30.38 |
$364,573 |
D/D |
(12,000) |
61,406 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-11-24 |
4 |
AS |
$35.02 |
$384,336 |
D/D |
(10,974) |
61,406 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-11-24 |
4 |
OE |
$6.88 |
$75,501 |
D/D |
10,974 |
72,380 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-12-05 |
4 |
OE |
$6.88 |
$48,339 |
D/D |
7,026 |
68,432 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-12-05 |
4 |
AS |
$35.06 |
$246,360 |
D/D |
(7,026) |
61,406 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-12-06 |
4 |
OE |
$6.88 |
$137,600 |
D/D |
20,000 |
81,406 |
0 |
- |
|
60 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
